{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:31:51Z","timestamp":1791466311507,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Taipei Hospital, Ministry of Health and Welfare, New Taipei City, Taiwan","award":["TH-202408"],"award-info":[{"award-number":["TH-202408"]}]},{"name":"Ministry of Health and Welfare, Taiwan, awarded to the affiliated Taipei Hospital","award":["11003"],"award-info":[{"award-number":["11003"]}]},{"name":"Ministry of Health and Welfare, Taiwan, awarded to the affiliated Taipei Hospital","award":["11103"],"award-info":[{"award-number":["11103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The roles of p53 and HER2 in gastric adenocarcinoma (GAC) have been extensively studied; nevertheless, the contribution of mitochondrial transcription factor A (TFAM) remains unclear. Concerning TFAM\u2019s pivotal role in mitochondrial biogenesis, this study aimed to evaluate the TFAM expression in GAC and to assess its associations with p53 and HER2 expressions and clinicopathological outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively analyzed 77 GAC patients who underwent upfront gastrectomy at Taipei Hospital between 2012 and 2021. Their clinicopathological profiles were recorded in detail. Immunohistochemical (IHC) staining for TFAM, p53, and HER2 protein expressions was semiquantified using IHC pixelwise H-score analyzed by ImageJ plugins IHC profiler. Associations between two continuous variables were assessed by Spearman\u2019s correlation coefficient (CC), and trendlines were fitted using SPSS\u2019s curve estimation function. The optimal cutoff for survival discrimination was derived from receiver operating characteristic (ROC) curve analysis by selecting the threshold with the highest Youden index and area under the curve (AUC). Prognostic variables with a Log-rank test\n                      <jats:italic>p<\/jats:italic>\n                      -value\u2009\u2264\u20090.1 were entered into a multi-variate Cox proportional hazards regression (Cox regression) model to identify independent ones and their relative hazards ratio (HR).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      TFAM IHC pixelwise H-score was significantly associated with advanced T and N status, lymphovascular invasion, perineural invasion and poor differentiation (all\u2019s\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), and was inversely correlated with tumor size (Spearman\u2019s rho CC = -0.402,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) in a logarithmic distribution (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). A positive correlation (Spearman\u2019s rho CC\u2009=\u20090.312,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006) in cubic distribution (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) was observed between p53and TFAM IHC pixelwise H-scores. ROC analysis yielded a TFAM IHC pixelwise H-score cutoff of 43.0 (AUC\u2009=\u20090.650, 95%CI\u2009=\u20090.515\u20130.785,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.047; sensitivity\u2009=\u20090.490, specificity\u2009=\u20090.810) to dichotomize high and low groups. In multi-variate Cox regression, low TFAM IHC pixelwise H-score (HR\u2009=\u20092.332, 95%CI\u2009=\u20091.136\u20134.787,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021), M1 status (HR\u2009=\u20093.582, 95%CI\u2009=\u20091.608\u20137.979,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), and perineural invasion (HR\u2009=\u20094.506, 95%CI\u2009=\u20091.541\u201313.177,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006) were identified as independent variables to poor prognosis with elevated HRs. Among patients with high TFAM expression, higher HER2 IHC pixelwise H-score was associated with elevated hazard (HR\u2009=\u20091.010, 95%CI\u2009=\u20091.002\u20131.019,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.020, Cox regression, uni-variate). Among M1 patients, higher p53 IHC pixelwise H-score was related to elevated hazard (HR\u2009=\u20091.029, 95%CI\u2009=\u20091.004\u20131.056,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025, Cox regression, uni-variate).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ROC and multi-variate Cox regression identified low TFAM expression as an independent poor prognostic variable for operable GAC patients, implying its potential as a quantitative prognostic biomarker. The observed associations with p53 and HER2 are hypothesis-generating and they require further validation to clarify TFAM\u2019s role in Warburg effect and GAC progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-025-03998-6","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:19:08Z","timestamp":1765808348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Semiquantitative immunohistochemical (IHC) pixelwise H-score of mitochondrial transcription factor A (TFAM) in gastric adenocarcinoma (GAC): clinicopathological significance and association with p53 and HER2"],"prefix":"10.1186","volume":"23","author":[{"given":"Liang-Hung","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ting","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-I","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0475-3689","authenticated-orcid":false,"given":"Yung-Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0481-4215","authenticated-orcid":false,"given":"Wan-Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Sung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiang-Ting","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"3998_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18:534\u201342.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3998_CR2","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.21873\/invivo.13641","volume":"38","author":"JH Park","year":"2024","unstructured":"Park JH, Seo AN, Kim M. Diagnostic usefulness of p53 immunostaining in gastric cancer and dysplasia: a real-world clinical experience. In Vivo. 2024;38:1865\u201374.","journal-title":"In Vivo"},{"key":"3998_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133247","volume":"274","author":"RR Malla","year":"2024","unstructured":"Malla RR, Nellipudi HR, Srilatha M, Nagaraju GP. HER-2 positive gastric cancer: current targeted treatments. Int J Biol Macromol. 2024;274:133247.","journal-title":"Int J Biol Macromol"},{"key":"3998_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03534-0","author":"S-n Wang","year":"2024","unstructured":"Wang S-n, Wang Y-k, Zhu C-y, Jiang B, Ge D-f, Li Y-y. Significance of concurrent evaluation of HER2 gene amplification and p53 and Ki67 expression in gastric cancer tissues. Clin Transl Oncol. 2024. https:\/\/doi.org\/10.1007\/s12094-024-03534-0.","journal-title":"Clin Transl Oncol"},{"key":"3998_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12094-023-03278-3","volume":"26","author":"J Liu","year":"2024","unstructured":"Liu J, Bai X, Zhang M, Wu S, Xiao J, Zeng X, et al. Energy metabolism: a new target for gastric cancer treatment. Clin Transl Oncol. 2024;26:338\u201351.","journal-title":"Clin Transl Oncol"},{"key":"3998_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314.","journal-title":"Science"},{"key":"3998_CR7","doi-asserted-by":"crossref","unstructured":"Martins Pinto M, Paumard P, Bouchez C, Ransac S, Duvezin-Caubet S, Mazat JP, Rigoulet M, Devin A. The Warburg effect and mitochondrial oxidative phosphorylation: friends or foes? Biochim Biophys Acta. 2023;1864:148931.","DOI":"10.1016\/j.bbabio.2022.148931"},{"key":"3998_CR8","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.3390\/ijms25179458","volume":"25","author":"H-T Lee","year":"2024","unstructured":"Lee H-T, Lin C-S, Liu C-Y, Chen P, Tsai C-Y, Wei Y-H. Mitochondrial plasticity and glucose metabolic alterations in human cancer under oxidative stress\u2014from viewpoints of chronic inflammation and neutrophil extracellular traps (NETs). Int J Mol Sci. 2024;25:9458.","journal-title":"Int J Mol Sci"},{"key":"3998_CR9","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2013.0442","volume":"369","author":"KB Busch","year":"2014","unstructured":"Busch KB, Kowald A, Spelbrink JN. Quality matters: how does mitochondrial network dynamics and quality control impact on MtDNA integrity? Philos Trans R Soc Lond B Biol Sci. 2014;369:20130442.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"3998_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-biochem-052621-092014","volume":"93","author":"M Falkenberg","year":"2024","unstructured":"Falkenberg M, Larsson N-G, Gustafsson CM. Replication and transcription of human mitochondrial DNA. Annu Rev Biochem. 2024;93:47\u201377.","journal-title":"Annu Rev Biochem"},{"key":"3998_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4093\/dmj.2021.0138","volume":"45","author":"J-H Koh","year":"2021","unstructured":"Koh J-H, Kim Y-W, Seo D-Y, Sohn T-S. Mitochondrial TFAM as a signaling regulator between cellular organelles: a perspective on metabolic diseases. Diabetes Metab J. 2021;45:853\u201365.","journal-title":"Diabetes Metab J"},{"key":"3998_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41420-024-01926-3","volume":"10","author":"T Lei","year":"2024","unstructured":"Lei T, Rui Y, Xiaoshuang Z, Jinglan Z, Jihong Z. Mitochondria transcription and cancer. Cell Death Discov. 2024;10:168.","journal-title":"Cell Death Discov"},{"key":"3998_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1101\/gad.309062.117","volume":"32","author":"S Basu","year":"2018","unstructured":"Basu S, Gnanapradeepan K, Barnoud T, Kung C-P, Tavecchio M, Scott J, Watters A, Chen Q, Kossenkov AV, Murphy ME. Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1\u03b1. Genes Dev. 2018;32:230\u201343.","journal-title":"Genes Dev"},{"key":"3998_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01756-w","volume":"9","author":"L Qian","year":"2024","unstructured":"Qian L, Zhu Y, Deng C, Liang Z, Chen J, Chen Y, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases. Signal Transduct Target Ther. 2024;9:50.","journal-title":"Signal Transduct Target Ther"},{"key":"3998_CR15","doi-asserted-by":"crossref","unstructured":"Rius-P\u00e9rez S, Torres-Cuevas I, Mill\u00e1n I, Ortega \u00c1L, P\u00e9rez S. PGC-1\u03b1, inflammation, and oxidative stress: an integrative view in metabolism. Oxid Med Cell Longev. 2020;2020:1452696.","DOI":"10.1155\/2020\/1452696"},{"key":"3998_CR16","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-18-0430","volume":"78","author":"A Ruiz-Saenz","year":"2018","unstructured":"Ruiz-Saenz A, Dreyer C, Campbell MR, Steri V, Gulizia N, Moasser MM. HER2 amplification in tumors activates PI3K\/Akt signaling independent of HER3. Cancer Res. 2018;78:3645\u201358.","journal-title":"Cancer Res"},{"key":"3998_CR17","doi-asserted-by":"publisher","first-page":"e38508","DOI":"10.1097\/MD.0000000000038508","volume":"103","author":"L Pan","year":"2024","unstructured":"Pan L, Li J, Xu Q, Gao Z, Yang M, Wu X, Li X. HER2\/PI3K\/AKT pathway in HER2-positive breast cancer: a review. Medicine (Baltimore). 2024;103:e38508.","journal-title":"Med (Baltim)"},{"key":"3998_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000356201","volume":"89","author":"Y Sukawa","year":"2014","unstructured":"Sukawa Y, Yamamoto H, Nosho K, Ito M, Igarashi H, Naito T, Mitsuhashi K, Matsunaga Y, Takahashi T, Mikami M, et al. HER2 expression and PI3K-Akt pathway alterations in gastric cancer. Digestion. 2014;89:12\u20137.","journal-title":"Digestion"},{"key":"3998_CR19","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1158\/0008-5472.CAN-21-2647","volume":"81","author":"AM Hosios","year":"2021","unstructured":"Hosios AM, Manning BD. Cancer signaling drives cancer metabolism: AKT and the Warburg effect. Cancer Res. 2021;81:4896\u20138.","journal-title":"Cancer Res"},{"issue":"4","key":"3998_CR20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/JCMA.0000000000000500","volume":"84","author":"Y-J Chen","year":"2021","unstructured":"Chen Y-J, Yeh S-T, Ou L-H, Lin C-S, Chien C-T. Impact of the extent of negative lymph nodes in gastric adenocarcinoma undergoing primary surgical resection: an institutional report. J Chin Med Assoc. 2021;84(4):428\u201337.","journal-title":"J Chin Med Assoc"},{"key":"3998_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.62713\/aic.3552","volume":"96","author":"C-H Lee","year":"2025","unstructured":"Lee C-H, Lee H-T, Yeh S-T, Tsai C-Y, Lien H-H, Lin C-S. A reappraisal of lymph node dissection for gastric adenocarcinoma during upfront gastrectomy\u2014an institutional report. Ann Ital Chir. 2025;96:228\u201343.","journal-title":"Ann Ital Chir"},{"key":"3998_CR22","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139.","journal-title":"CA Cancer J Clin"},{"key":"3998_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245638","volume":"16","author":"S Ram","year":"2021","unstructured":"Ram S, Vizcarra P, Whalen P, Deng S, Painter C, Jackson-Fisher A, et al. Pixelwise H-score: a novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images. PLoS ONE. 2021;16:e0245638.","journal-title":"PLoS One"},{"key":"3998_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4103\/fjs.fjs_15_20","volume":"53","author":"C-S Lin","year":"2020","unstructured":"Lin C-S, Yeh Y-C, Pan S-C, Lu S-Y, Chen Y-J, Chueh W-Y, et al. Role of mitochondrial DNA copy number alteration in non-small cell lung cancer. Formosan J Surg. 2020;53:165\u201376.","journal-title":"Formosan J Surg"},{"key":"3998_CR25","doi-asserted-by":"publisher","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese F, Bukhari AB, Malhotra R, De A. IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE. 2014;9:e96801.","journal-title":"PLoS One"},{"key":"3998_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/aca.ACA_157_18","volume":"22","author":"P Mishra","year":"2019","unstructured":"Mishra P, Pandey CM, Singh U, Gupta A, Sahu C, Keshri A. Descriptive statistics and normality tests for statistical data. Ann Card Anaesth. 2019;22:67\u201372.","journal-title":"Ann Card Anaesth"},{"key":"3998_CR27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biom J. 2005;47:458\u201372.","journal-title":"Biom J"},{"key":"3998_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10120-012-0179-9","volume":"16","author":"K Shitara","year":"2013","unstructured":"Shitara K, Yatabe Y, Matsuo K, Sugano M, Kondo C, Takahari D, Ura T, Tajika M, Ito S, Muro K. Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment. Gastric Cancer. 2013;16:261\u20137.","journal-title":"Gastric Cancer"},{"key":"3998_CR29","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1093\/annonc\/mdt232","volume":"24","author":"WQ Sheng","year":"2013","unstructured":"Sheng WQ, Huang D, Ying JM, Lu N, Wu HM, Liu YH, et al. HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance. Ann Oncol. 2013;24:2360\u20134.","journal-title":"Ann Oncol"},{"key":"3998_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.7314\/APJCP.2015.16.1.327","volume":"16","author":"M Yildirim","year":"2015","unstructured":"Yildirim M, Kaya V, Demirpence O, Gunduz S, Bozcuk H. Prognostic significance of p53 in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev. 2015;16:327\u201332.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3998_CR31","doi-asserted-by":"publisher","first-page":"11228","DOI":"10.3390\/ijms130911228","volume":"13","author":"C-S Lin","year":"2012","unstructured":"Lin C-S, Lee H-T, Lee S-Y, Shen Y-A, Wang L-S, Chen Y-J, et al. High mitochondrial DNA copy number and bioenergetic function are associated with tumor invasion of esophageal squamous cell carcinoma cell lines. Int J Mol Sci. 2012;13:11228\u201346.","journal-title":"Int J Mol Sci"},{"key":"3998_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17060814","author":"C-S Lin","year":"2016","unstructured":"Lin C-S, Lee H-T, Lee M-H, Pan S-C, Ke C-Y, Chiu AW-H, et al. Role of mitochondrial DNA copy number alteration in human renal cell carcinoma. Int J Mol Sci. 2016. https:\/\/doi.org\/10.3390\/ijms17060814.","journal-title":"Int J Mol Sci"},{"key":"3998_CR33","first-page":"316","volume":"39","author":"C-S Lin","year":"2018","unstructured":"Lin C-S, Liu L-T, Ou L-H, Pan S-C, Lin C-I, Wei Y-H. Role of mitochondrial function in the invasiveness of human colon cancer cells. Oncol Rep. 2018;39:316\u201330.","journal-title":"Oncol Rep"},{"key":"3998_CR34","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3390\/ijms23031857","volume":"23","author":"T-C Chang","year":"2022","unstructured":"Chang T-C, Lee H-T, Pan S-C, Cho S-H, Cheng C, Ou L-H, Lin C-I, Lin C-S, Wei Y-H. Metabolic reprogramming in response to alterations of mitochondrial DNA and mitochondrial dysfunction in gastric adenocarcinoma. Int J Mol Sci. 2022;23:1857.","journal-title":"Int J Mol Sci"},{"key":"3998_CR35","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/s41419-021-04255-w","volume":"12","author":"Y-T Hsieh","year":"2021","unstructured":"Hsieh Y-T, Tu H-F, Yang M-H, Chen Y-F, Lan X-Y, Huang C-L, Chen H-M, Li W-C. Mitochondrial genome and its regulator TFAM modulates head and neck tumourigenesis through intracellular metabolic reprogramming and activation of oncogenic effectors. Cell Death Dis. 2021;12:961.","journal-title":"Cell Death Dis"},{"key":"3998_CR36","doi-asserted-by":"publisher","first-page":"e110324","DOI":"10.15252\/embj.2021110324","volume":"41","author":"Q Huang","year":"2022","unstructured":"Huang Q, Wu D, Zhao J, Yan Z, Chen L, Guo S, Wang D, Yuan C, Wang Y, Liu X, Xing J. TFAM loss induces nuclear actin assembly upon mDia2 malonylation to promote liver cancer metastasis. EMBO J. 2022;41:e110324.","journal-title":"EMBO J"},{"key":"3998_CR37","doi-asserted-by":"publisher","first-page":"11609","DOI":"10.18632\/oncotarget.7018","volume":"7","author":"D Xie","year":"2016","unstructured":"Xie D, Wu X, Lan L, Shangguan F, Lin X, Chen F, Xu S, Zhang Y, Chen Z, Huang K. Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK\/p38MAPK signaling and reducing cellular bioenergetics. Oncotarget. 2016;7:11609.","journal-title":"Oncotarget"},{"key":"3998_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semcancer.2022.12.011","volume":"88","author":"C Liao","year":"2023","unstructured":"Liao C, Liu X, Zhang C, Zhang Q. Tumor hypoxia: from basic knowledge to therapeutic implications. Semin Cancer Biol. 2023;88:172\u201386.","journal-title":"Semin Cancer Biol"},{"key":"3998_CR39","doi-asserted-by":"publisher","first-page":"153303382110363","DOI":"10.1177\/15330338211036304","volume":"20","author":"Y Li","year":"2021","unstructured":"Li Y, Zhao L, Li XF. Hypoxia and the tumor microenvironment. Technol Cancer Res Treat. 2021;20:15330338211036304.","journal-title":"Technol Cancer Res Treat"},{"key":"3998_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.cellsig.2017.07.008","volume":"38","author":"AJ Zarrabi","year":"2017","unstructured":"Zarrabi AJ, Kao D, Nguyen DT, Loscalzo J, Handy DE. Hypoxia-induced suppression of c-Myc by HIF-2\u03b1 in human pulmonary endothelial cells attenuates TFAM expression. Cell Signal. 2017;38:230\u20137.","journal-title":"Cell Signal"},{"key":"3998_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jmcb\/mjz010","volume":"11","author":"K Sabapathy","year":"2019","unstructured":"Sabapathy K, Lane DP. Understanding p53 functions through p53 antibodies. J Mol Cell Biol. 2019;11:317\u201329.","journal-title":"J Mol Cell Biol"},{"key":"3998_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/1947601912454734","volume":"3","author":"W Hu","year":"2012","unstructured":"Hu W, Feng Z, Levine AJ. The regulation of multiple p53 stress responses is mediated through MDM2. Genes Cancer. 2012;3:199\u2013208.","journal-title":"Genes Cancer"},{"key":"3998_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/cancers11010004","volume":"11","author":"S Yamamoto","year":"2019","unstructured":"Yamamoto S, Iwakuma T. Regulators of oncogenic mutant TP53 gain of function. Cancers. 2019;11:4.","journal-title":"Cancers"},{"key":"3998_CR44","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1101\/gad.340976.120","volume":"34","author":"J Gencel-Augusto","year":"2020","unstructured":"Gencel-Augusto J, Lozano G. P53 tetramerization: at the center of the dominant-negative effect of mutant p53. Genes Dev. 2020;34:1128\u201346.","journal-title":"Genes Dev"},{"key":"3998_CR45","doi-asserted-by":"publisher","first-page":"14710","DOI":"10.1038\/s41598-018-32887-0","volume":"8","author":"K Beyfuss","year":"2018","unstructured":"Beyfuss K, Erlich AT, Triolo M, Hood DA. The role of p53 in determining mitochondrial adaptations to endurance training in skeletal muscle. Sci Rep. 2018;8:14710.","journal-title":"Sci Rep"},{"key":"3998_CR46","doi-asserted-by":"publisher","first-page":"19626","DOI":"10.1073\/pnas.1904979116","volume":"116","author":"J Li","year":"2019","unstructured":"Li J, Wang PY, Long NA, Zhuang J, Springer DA, Zou J, et al. p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities. Proc Natl Acad Sci USA. 2019;116:19626\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3998_CR47","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026179","author":"P Hainaut","year":"2016","unstructured":"Hainaut P, Pfeifer GP. Somatic TP53 mutations in the era of genome sequencing. Cold Spring Harb Perspect Med. 2016. https:\/\/doi.org\/10.1101\/cshperspect.a026179.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3998_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1593\/neo.04373","volume":"7","author":"MI Koukourakis","year":"2005","unstructured":"Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL, Tumor, Angiogenesis Research G. Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia. 2005;7:1\u20136.","journal-title":"Neoplasia"},{"key":"3998_CR49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41:211\u20138.","journal-title":"Trends Biochem Sci"},{"key":"3998_CR50","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.asjsur.2022.06.039","volume":"46","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wang M, Wang Y, Cheng X, Jiang Y, Xiao H. Clinicopathologic significance of Her-2 and P(53) expressions in gastric cancer. Asian J Surg. 2023;46:526\u201331.","journal-title":"Asian J Surg"},{"key":"3998_CR51","doi-asserted-by":"publisher","first-page":"e88907","DOI":"10.1371\/journal.pone.0088907","volume":"9","author":"J Deng","year":"2014","unstructured":"Deng J, You Q, Gao Y, Yu Q, Zhao P, Zheng Y, et al. Prognostic value of perineural invasion in gastric cancer: a systematic review and meta-analysis. PLoS ONE. 2014;9:e88907.","journal-title":"PLoS One"},{"key":"3998_CR52","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1200\/JCO.2009.22.4949","volume":"27","author":"C Liebig","year":"2009","unstructured":"Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol. 2009;27:5131\u20137.","journal-title":"J Clin Oncol"},{"key":"3998_CR53","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/archotol.124.6.637","volume":"124","author":"JJ Fagan","year":"1998","unstructured":"Fagan JJ, Collins B, Barnes L, D\u2019Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:637\u201340.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"3998_CR54","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2015.02.002","volume":"42","author":"E Weinberg Samuel","year":"2015","unstructured":"Weinberg Samuel E, Sena Laura A, Chandel Navdeep S. Mitochondria in the regulation of innate and adaptive immunity. Immunity. 2015;42:406\u201317.","journal-title":"Immunity"},{"key":"3998_CR55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3892\/ol.2025.14926","volume":"29","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhang B, Wang X, Chen Y, Anwar M, Fan J, Ma B. Prognostic value of preoperative modified Glasgow prognostic score in predicting overall survival in breast cancer patients: a retrospective cohort study. Oncol Lett. 2025;29:180.","journal-title":"Oncol Lett"},{"key":"3998_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3892\/ol.2025.14943","volume":"29","author":"K Li","year":"2025","unstructured":"Li K, Zeng X, Zhang Z, Wang K, Pan Y, Wu Z, Chen Y, Zhao Z. Pan\u2013immune\u2013inflammatory values predict survival in patients after radical surgery for non\u2013metastatic colorectal cancer: a retrospective study. Oncol Lett. 2025;29:197.","journal-title":"Oncol Lett"},{"key":"3998_CR57","volume":"31","author":"KJ Li","year":"2025","unstructured":"Li KJ, Zhang ZY, Wang K, Sulayman S, Zeng XY, Liu J, et al. Prognostic scoring system using inflammation- and nutrition-related biomarkers to predict prognosis in stage I-III colorectal cancer patients. World J Gastroenterol. 2025;31:104588.","journal-title":"World J Gastroenterol"},{"key":"3998_CR58","doi-asserted-by":"publisher","unstructured":"Chen Y, Anwar M, Wang X, Zhang B, Ma B. Integrative transcriptomic and single-cell analysis reveals IL27RA as a key immune regulator and therapeutic indicator in breast cancer. Discov Oncol. 2025;16(1):977. https:\/\/doi.org\/10.1007\/s12672-025-02811-w.","DOI":"10.1007\/s12672-025-02811-w"},{"key":"3998_CR59","doi-asserted-by":"publisher","unstructured":"Li B, Lin R, Hua Y, Ma B, Chen Y. Single\u2011cell RNA sequencing reveals TMEM71 as an immunomodulatory biomarker predicting immune checkpoint blockade response in breast cancer. Discov Oncol. 2025;16(1):1256. https:\/\/doi.org\/10.1007\/s12672-025-03068-z.","DOI":"10.1007\/s12672-025-03068-z"},{"key":"3998_CR60","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.media.2016.06.037","volume":"33","author":"A Madabhushi","year":"2016","unstructured":"Madabhushi A, Lee G. Image analysis and machine learning in digital pathology: challenges and opportunities. Med Image Anal. 2016;33:170\u20135.","journal-title":"Med Image Anal"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03998-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03998-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:03:01Z","timestamp":1785736981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-03998-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3998"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03998-6","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated: Affiliations 1 and 14 were interchanged.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study and the waiver of the participants\u2019 consent was approved by the Institutional Review Board of Taipei Hospital, Ministry of Health and Welfare, New Taipei City, Taiwan (Approval Nos. TH-IRB-0018-0022, TH-IRB-0022-0010, and TH-IRB-0024-002), as well as the Institutional Review Board of Taoyuan Hospital, Ministry of Health and Welfare, Taoyuan City, Taiwan (Approval No. TYGH-114026).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"452"}}